Enter assignee name

Anovent Pharmaceutical (u.s.), LLC

Patents = 5

Trademarks = 2

Forward Citations = 0

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

8 inventors (with patents filed for the assignee):

Cai Gu Huang (5 out of 6 patents)

Ning He (1 out of 15 patents)

Yue Zhao (1 out of 22 patents)

4. Hitesh Bhagavanbhai Mangukiya (1 out of 1 patent)

5. Hailong Zhang (1 out of 15 patents)

6. Abid Hussain (1 out of 1 patent)

7. Ying Xu (1 out of 9 patents)

8. Hui Yuan (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11642333 - Inhalable formulation of a solution containing vilanterol trifenatate and umeclidinium bromide (2023-05-09),

2. 11369760 - Inhalation atomizer comprising a blocking function and a counter (2022-06-28),

3. 11365248 - Formulation of tocilizumab and method for treating COVID-19 by inhalation (2022-06-21),

4. 11304901 - Liposome formulation of fluticasone furoate and method of preparation (2022-04-19),

5. 11304897 - Pharmaceutical formulation containing umeclidinium bromide and vilanterol trifenatate (2022-04-19),

Anovent Pharmaceutical (U.S.), LLC is a research-driven biopharmaceutical company dedicated to developing innovative therapies for respiratory diseases. The company's focus is on advancing treatments for conditions such as asthma, COPD, and pulmonary fibrosis. With a commitment to improving patient outcomes and quality of life, Anovent strives to be a leader in the field of respiratory medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

5 Patents

#29 in Newark, NJ

#1,878 in New Jersey

#50,145 in US

Newark, NJ, United States of America